Endometrial Stromal SarcomaSymptoms, Doctors, Treatments, Advances & More
Learn About Endometrial Stromal Sarcoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Rockefeller Outpatient Pavilion
Mario Leitao is a Gynecologic Oncologist and an Oncologist practicing medicine in New York, New York. Dr. Leitao is rated as an Elite provider by MediFind in the treatment of Endometrial Stromal Sarcoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Vulvar Cancer, Vaginal Cancer, Hysterectomy, and Lymphadenectomy. Dr. Leitao is currently accepting new patients.
Tower Health Medical Group Gynecologic Oncology - West Reading
John Villeneuve is an Oncologist and an Obstetrics and Gynecologist practicing medicine in West Reading, Pennsylvania. Dr. Villeneuve is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Vulvar Cancer, Endometrial Cancer, Endometrial Stromal Sarcoma, Bladder Reconstruction, and Hysterectomy. Dr. Villeneuve is board certified in American Board Of Obstetrics And Gynecology.
Fred & Pamela Buffett Cancer Center - Nebraska Medical Center
Kerry Rodabaugh is an Oncologist practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 36 years. Dr. Rodabaugh is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, and Bladder Reconstruction.
Summary: The primary objective is to compare the progression-free survival (PFS) between aromatase inhibitors interruption and aromatase inhibitors maintenance strategies in patients with a locally advanced or metastatic Low Grade Endometrial Stromal Sarcoma (LGESS).
Summary: This study will evaluate the safety and efficacy of MASCT-I combined with Doxorubicin and Ifosfamide for first-line treatment in patients with advanced soft tissue sarcoma.